|
|
|
Liver Clinical Trials |
|
Thank you for your interest in clinical trials for Liver
Please click "Search" to find Liver clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
|
|
Your search returned 2 studies:
|
|
|
|
|
Results from other databases:
|
|
Your search returned over 250 results. The top 250 results are being displayed. Please use
additional keywords or decrease the search distance. |
|
Your search returned 250 studies:
- 4D PET/CT Imaging in Lung and Colorectal Cancer With Liver Metastasis - NCT00862680-77030
Conditions: Colorectal Cancer - Lung Cancer - Liver Cancer
Location: Houston, TX
- A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis - NCT00930384-20037
Conditions: Psoriasis
Location: Washington, DC
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-02115
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Boston, MA
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-10029
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: New York, NY
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-10032
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: New York, NY
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-15224
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Pittsburgh, PA
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-19104
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Philadelphia, PA
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-21287
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Baltimore, MD
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-30322
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Atlanta, GA
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-45229
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Cincinnati, OH
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-46202
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Indianapolis, IN
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-48109
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Ann Arbor, MI
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-60614
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Chicago, IL
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-63110
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: St. Louis, MO
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-75235
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Dallas, TX
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-77030
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Houston, TX
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-80218
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Denver, CO
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-94143
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: San Francisco, CA
- A Multi-Center Group to Study Acute Liver Failure in Children - NCT00986648-98105
Conditions: Acute Liver Failure - Hepatic Encephalopathy
Location: Seattle, WA
- A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible. - NCT00152087-33607
Conditions: Liver Cancer
Location: Tampa, FL
- A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) - NCT00821002-94025
Conditions: Open-Angle Glaucoma - Ocular Hypertension
Location: Menlo Park, CA
- A Phase I Study of Alemtuzumab Delivered Intraperitoneally in Patients With Relapsed Ovarian Cancer - NCT00637390-48109
Conditions: Recurrent Ovarian Cancer Not Responsive to Standard Chemo
Location: Ann Arbor, MI
- A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) - NCT00746317-02114
Conditions: Advanced or Metastatic HCC
Location: Boston, MA
- A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) - NCT00746317-02115A
Conditions: Advanced or Metastatic HCC
Location: Boston, MA
- A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) - NCT00746317-02115B
Conditions: Advanced or Metastatic HCC
Location: Boston, MA
- A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) - NCT00746317-48201
Conditions: Advanced or Metastatic HCC
Location: Detroit, MI
- A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) - NCT00746317-90033
Conditions: Advanced or Metastatic HCC
Location: Los Angeles, CA
- A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) - NCT00746317-98104
Conditions: Advanced or Metastatic HCC
Location: Seattle, WA
- A Phase I Study of Pazopanib in Adult Patients With Liver Cancer - NCT00370513-94115
Conditions: Liver Cancer
Location: San Francisco, CA
- A Phase II Dose-Escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure - NCT00721045-55407
Conditions: Heart Failure
Location: Minneapolis, MN
- A Phase II Dose-Escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure - NCT00721045-77030
Conditions: Heart Failure
Location: Houston, TX
- A Phase II Dose-Escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure - NCT00721045-85297
Conditions: Heart Failure
Location: Gilbert, AZ
- A Phase II Dose-Escalation Study to Assess the Feasibility and Safety of Transendocardial Delivery of Three Different Doses of Allogeneic Mesenchymal Precursor Cells (MPCs)in Subjects With Heart Failure - NCT00721045-92037
Conditions: Heart Failure
Location: La Jolla, CA
- A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma - NCT00183885-90033
Conditions: Hepatocellular Carcinoma - Liver Cancer
Location: Los Angeles, CA
- A Pilot Study of Siliphos in Adults With Non-Alcoholic Steatohepatitis (NASH) - NCT00443079-92103
Conditions: Fatty Liver
Location: San Diego, CA
- A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH) - NCT00799578-92103
Conditions: Fatty Liver
Location: San Diego, CA
- A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant Recipients - NCT00336817-15213
Conditions: Immunosuppression
Location: Pittsburgh, PA
- A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase® - NCT0092
Conditions: Hunter Syndrome
Location: Chapel Hill, NC
- A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease - NCT00969332-90095
Conditions: Parenteral Nutrition Associated Cholestasis
Location: Los Angeles, CA
- A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma - NCT00820300-94025
Conditions: Glaucoma - Ocular Hypertension
Location: Menlo Park, CA
- A Study Comparing Two Spinal Techniques for for Cesarean Delivery Anesthesia - NCT00990574-94305
Conditions: Hypotension - Headache
Location: Stanford, CA
- A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction - NCT00437424-35294
Conditions: Carcinoma, Hepatocellular
Location: Birmingham, AL
- A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction - NCT00437424-44106
Conditions: Carcinoma, Hepatocellular
Location: Clleveland, OH
- A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction - NCT00437424-78229
Conditions: Carcinoma, Hepatocellular
Location: San Antonio, TX
- A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction - NCT00437424-90033
Conditions: Carcinoma, Hepatocellular
Location: Los Angeles, CA
- A Study of Different Formulations of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma - NCT00967811-94025
Conditions: Glaucoma - Ocular Hypertension
Location: Menlo Park, CA
- A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver - NCT00906373-60611
Conditions: Hepatocellular Carcinoma
Location: Chicago, IL
- A Study of IMC-A12 in Combination With Sorafenib in Patients With Advanced Cancer of the Liver - NCT00906373-70006
Conditions: Hepatocellular Carcinoma
Location: Metairie, LA
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area - NCT00913757-
Conditions: Carcinoma, Hepatocellular - Liver Cirrhosis, Alcoholic - Hepatitis, Alcoholic - Hepatitis, Chronic - Hepatitis, Viral, Human
Location: Baltimore, MD
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area - NCT00913757-20892
Conditions: Carcinoma, Hepatocellular - Liver Cirrhosis, Alcoholic - Hepatitis, Alcoholic - Hepatitis, Chronic - Hepatitis, Viral, Human
Location: Bethesda, MD
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area - NCT00913757-21205
Conditions: Carcinoma, Hepatocellular - Liver Cirrhosis, Alcoholic - Hepatitis, Alcoholic - Hepatitis, Chronic - Hepatitis, Viral, Human
Location: Baltimore, MD
- A Study to Assess PV-10 Chemoablation of Cancer of the Liver - NCT00986661-92123
Conditions: Cancer Metastatic to the Liver - Recurrent Hepatocellular Carcinoma
Location: San Diego, CA
- A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere® - NCT00877136-92868
Conditions: Liver Tumors - Hepatocellular Carcinoma - Hepatoma - Neoplasms
Location: Orange, CA
- A Trial of Bed Versus Stirrups Delivery in Nulliparous Women for Prevention of Perineal Lacerations - NCT00895973-75235
Conditions: Perineal Lacerations
Location: Dallas, TX
- A2ALL Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC) - NCT00866957-60611
Conditions: Liver Cancer
Location: Chicago, IL
- Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation - NCT01007357-68198
Conditions: Diffuse and Focal Abnormalities of the Liver and Pancreas
Location: Omaha, NE
- Acceptability of Less Harmful Alternatives to Cigarettes - NCT00957424-14263
Conditions: Bladder Cancer - Cervical Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Kidney Cancer - Leukemia - Liver Cancer - Lung Cancer - Pancreatic Cancer - Tobacco Use Disorder
Location: Buffalo, NY
- An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma - NCT00880061-20892
Conditions: Brain Neoplasm - Glioma
Location: Bethesda, MD
- Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - NCT00395018-14642
Conditions: Hepatitis B, Chronic
Location: Rochester, NY
- Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - NCT00395018-45267
Conditions: Hepatitis B, Chronic
Location: Cincinnati, OH
- Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - NCT00395018-55905
Conditions: Hepatitis B, Chronic
Location: Rochester, MN
- Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - NCT00395018-60611
Conditions: Hepatitis B, Chronic
Location: Chicago, IL
- Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - NCT00395018-68198
Conditions: Hepatitis B, Chronic
Location: Omaha, NE
- Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - NCT00395018-70112
Conditions: Hepatitis B, Chronic
Location: New Orleans, LA
- Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - NCT00395018-75246
Conditions: Hepatitis B, Chronic
Location: Dallas, TX
- Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection - NCT00395018-77030
Conditions: Hepatitis B, Chronic
Location: Houston, TX
- Assessment of Insulin Resistance, NAFLD, Predictors of CV Morbidity, and Subcutaneous Adipose and Visceral Adipose Gene Expression in Patients Undergoing Gastric Bypass Surgery - NCT01007955-01655
Conditions: Morbid Obesity - Insulin Resistance - Non-Alcoholic Fatty Liver Disease
Location: Worcester, MA
- AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer - NCT00427973-02114
Conditions: Liver Cancer
Location: Boston, MA
- AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer - NCT00427973-02115
Conditions: Liver Cancer
Location: Boston, MA
- Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery - NCT00335829-21231
Conditions: Liver Cancer
Location: Baltimore, MD
- Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer - NCT00881751-29425
Conditions: Liver Cancer
Location: Charleston, SC
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-16801
Conditions: Liver Cancer
Location: State College, PA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-17822
Conditions: Liver Cancer
Location: Danville, PA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-18201
Conditions: Liver Cancer
Location: Hazleton, PA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-18711
Conditions: Liver Cancer
Location: Wilkes-Barre, PA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-49017
Conditions: Liver Cancer
Location: Battle Creek, MI
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-49307
Conditions: Liver Cancer
Location: Big Rapids, MI
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-49443
Conditions: Liver Cancer
Location: Muskegon, MI
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-49503A
Conditions: Liver Cancer
Location: Grand Rapids, MI
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-49503B
Conditions: Liver Cancer
Location: Grand Rapids, MI
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-49503C
Conditions: Liver Cancer
Location: Grand Rapids, MI
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-49519
Conditions: Liver Cancer
Location: Wyoming, MI
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-49684
Conditions: Liver Cancer
Location: Traverse City, MI
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-50309A
Conditions: Liver Cancer
Location: Des Moines, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-50309B
Conditions: Liver Cancer
Location: Des Moines, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-50309C
Conditions: Liver Cancer
Location: Des Moines, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-50314A
Conditions: Liver Cancer
Location: Des Moines, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-50314B
Conditions: Liver Cancer
Location: Des Moines, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-50316
Conditions: Liver Cancer
Location: Des Moines, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-50325
Conditions: Liver Cancer
Location: Clive, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-51101
Conditions: Liver Cancer
Location: Sioux City, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-51104A
Conditions: Liver Cancer
Location: Sioux City, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-51104B
Conditions: Liver Cancer
Location: Sioux City, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-52722
Conditions: Liver Cancer
Location: Bettendorf, IA
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55102
Conditions: Liver Cancer
Location: Saint Paul, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55109
Conditions: Liver Cancer
Location: Maplewood, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55125
Conditions: Liver Cancer
Location: Woodbury, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55337
Conditions: Liver Cancer
Location: Burnsville, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55379
Conditions: Liver Cancer
Location: Shakopee, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55387
Conditions: Liver Cancer
Location: Waconia, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55407
Conditions: Liver Cancer
Location: Minneapolis, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55416A
Conditions: Liver Cancer
Location: Saint Louis Park, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55416B
Conditions: Liver Cancer
Location: Saint Louis Park, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55422
Conditions: Liver Cancer
Location: Robbinsdale, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55432
Conditions: Liver Cancer
Location: Fridley, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55433
Conditions: Liver Cancer
Location: Coon Rapids, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55435
Conditions: Liver Cancer
Location: Edina, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55805A
Conditions: Liver Cancer
Location: Duluth, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55805B
Conditions: Liver Cancer
Location: Duluth, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55805C
Conditions: Liver Cancer
Location: Duluth, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-55905
Conditions: Liver Cancer
Location: Rochester, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-56601
Conditions: Liver Cancer
Location: Bemidji, MN
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-58122A
Conditions: Liver Cancer
Location: Fargo, ND
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-58122B
Conditions: Liver Cancer
Location: Fargo, ND
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-58501A
Conditions: Liver Cancer
Location: Bismarck, ND
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-58501B
Conditions: Liver Cancer
Location: Bismarck, ND
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-58501C
Conditions: Liver Cancer
Location: Bismarck, ND
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-58502
Conditions: Liver Cancer
Location: Bismarck, ND
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59101A
Conditions: Liver Cancer
Location: Billings, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59101B
Conditions: Liver Cancer
Location: Billings, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59101C
Conditions: Liver Cancer
Location: Billings, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59101D
Conditions: Liver Cancer
Location: Billings, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59107
Conditions: Liver Cancer
Location: Billings, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59405A
Conditions: Liver Cancer
Location: Great Falls, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59405B
Conditions: Liver Cancer
Location: Great Falls, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59501
Conditions: Liver Cancer
Location: Havre, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59601
Conditions: Liver Cancer
Location: Helena, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59701
Conditions: Liver Cancer
Location: Butte, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59715
Conditions: Liver Cancer
Location: Bozeman, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59801
Conditions: Liver Cancer
Location: Missoula, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59804
Conditions: Liver Cancer
Location: Missoula, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59807A
Conditions: Liver Cancer
Location: Missoula, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59807B
Conditions: Liver Cancer
Location: Missoula, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59901A
Conditions: Liver Cancer
Location: Kalispell, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59901B
Conditions: Liver Cancer
Location: Kalispell, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-59901C
Conditions: Liver Cancer
Location: Kalispell, MT
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61265A
Conditions: Liver Cancer
Location: Moline, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61265B
Conditions: Liver Cancer
Location: Moline, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61350A
Conditions: Liver Cancer
Location: Ottawa, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61350B
Conditions: Liver Cancer
Location: Ottawa, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61354
Conditions: Liver Cancer
Location: Peru, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61362
Conditions: Liver Cancer
Location: Spring Valley, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61401A
Conditions: Liver Cancer
Location: Galesburg, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61401B
Conditions: Liver Cancer
Location: Galesburg, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61455
Conditions: Liver Cancer
Location: Macomb, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61462
Conditions: Liver Cancer
Location: Monmouth, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61520
Conditions: Liver Cancer
Location: Canton, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61530
Conditions: Liver Cancer
Location: Eureka, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61554
Conditions: Liver Cancer
Location: Pekin, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61614
Conditions: Liver Cancer
Location: Peoria, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61615A
Conditions: Liver Cancer
Location: Peoria, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61615B
Conditions: Liver Cancer
Location: Peoria, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61636
Conditions: Liver Cancer
Location: Peoria, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61637
Conditions: Liver Cancer
Location: Peoria, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61701
Conditions: Liver Cancer
Location: Bloomington, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61761A
Conditions: Liver Cancer
Location: Normal, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-61761B
Conditions: Liver Cancer
Location: Normal, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-62321
Conditions: Liver Cancer
Location: Carthage, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-62644
Conditions: Liver Cancer
Location: Havana, IL
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-66044
Conditions: Liver Cancer
Location: Lawrence, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-66701
Conditions: Liver Cancer
Location: Fort Scott, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-66720
Conditions: Liver Cancer
Location: Chanute, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67003
Conditions: Liver Cancer
Location: Anthony, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67042A
Conditions: Liver Cancer
Location: El Dorado, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67042B
Conditions: Liver Cancer
Location: Salina, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67068
Conditions: Liver Cancer
Location: Kingman, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67114
Conditions: Liver Cancer
Location: Newton, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67124
Conditions: Liver Cancer
Location: Pratt, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67152
Conditions: Liver Cancer
Location: Wellington, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67156
Conditions: Liver Cancer
Location: Winfield, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67208A
Conditions: Liver Cancer
Location: Wichita, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67208B
Conditions: Liver Cancer
Location: Wichita, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67214A
Conditions: Liver Cancer
Location: Wichita, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67214B
Conditions: Liver Cancer
Location: Wichita, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67214C
Conditions: Liver Cancer
Location: Wichita, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67301
Conditions: Liver Cancer
Location: Independence, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67357
Conditions: Liver Cancer
Location: Parsons, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67801
Conditions: Liver Cancer
Location: Dodge City, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-67901
Conditions: Liver Cancer
Location: Liberal, KS
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-82801
Conditions: Liver Cancer
Location: Sheridan, WY
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer - NCT00867321-85259
Conditions: Liver Cancer
Location: Scottsdale, AZ
- Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study - NCT00340899-
Conditions: Maternal Fetal Factors
Location: Detroit, MI
- Biological Markers of Disease in the Prediction of Preterm Delivery, Preeclampsia and Intra-Uterine Growth Retardation: A Longtitudinal Study - NCT00340899-48073
Conditions: Maternal Fetal Factors
Location: Royal oak, MI
- Biomarker Study With SCH 900105 (Study P05670) - NCT00969410-07033
Conditions: Neoplasms Metastasis - Liver Metastases
Location: Kenilworth, NJ
- Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer - NCT00452946-20892
Conditions: Colorectal Cancer - Esophageal Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Gastric Cancer - Gastrointestinal Complications - Liver Cancer - Pancreatic Cancer - Radiation Toxicity
Location: Bethesda, MD
- Bone Marrow Radiation Therapy Followed by Busulfan, Melphalan, Thiotepa, and an Autologous Stem Cell Transplant in Treating Patients With High-Risk or Relapsed Solid Tumors - NCT00623077-55455
Conditions: Brain and Central Nervous System Tumors - Kidney Cancer - Liver Cancer - Retinoblastoma - Sarcoma - Unspecified Adult Solid Tumor, Protocol Specific - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Minneapolis, MN
- Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction - NCT00091117-15232
Conditions: Liver Cancer - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
Location: Pittsburgh, PA
- Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction - NCT00091117-44106
Conditions: Liver Cancer - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
Location: Cleveland, OH
- Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction - NCT00091117-48201
Conditions: Liver Cancer - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
Location: Detroit, MI
- Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction - NCT00091117-53792
Conditions: Liver Cancer - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
Location: Madison, WI
- Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction - NCT00091117-78229
Conditions: Liver Cancer - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
Location: San Antonio, TX
- Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction - NCT00091117-91010
Conditions: Liver Cancer - Lymphoma - Unspecified Adult Solid Tumor, Protocol Specific
Location: Duarte, CA
- Brachytherapy Radiation Directly to the Liver in Breast Cancer Patients With Metastatic to Liver - NCT00891800-33607
Conditions: Breast Cancer Metastatic to the Liver
Location: Tampa, FL
- Cediranib in Treating Young Patients With Refractory or Recurrent Solid Tumors or Acute Myeloid Leukemia - NCT00354848-19104
Conditions: Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Ovarian Cancer - Sarcoma - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Philadelphia, PA
- Cediranib in Treating Young Patients With Refractory or Recurrent Solid Tumors or Acute Myeloid Leukemia - NCT00354848-20892
Conditions: Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Ovarian Cancer - Sarcoma - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Bethesda, MD
- Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit - NCT00177931-15213
Conditions: Liver Transplantation
Location: Pittsburgh, PA
- Cesarean Delivery and Post-Operative Pain Management With Local Anesthesia - NCT00298571-33606
Conditions: Pain, Postoperative
Location: tampa, FL
- Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver - NCT00408551-46526
Conditions: Colorectal Cancer - Metastatic Cancer
Location: Goshen, IN
- Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery - NCT00875615-33136
Conditions: Liver Cancer
Location: Miami, FL
- Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer - NCT01008566-17033
Conditions: Liver Cancer
Location: Hershey, PA
- Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer - NCT01008566-90089
Conditions: Liver Cancer
Location: Los Angeles, CA
- Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer - NCT01008566-95817
Conditions: Liver Cancer
Location: Sacramento, CA
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-02115
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Boston, MA
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-06360
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Farmington, CT
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-07601
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Hackensack, NJ
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-08903
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: New Brunswick, NJ
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-10016
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: New York, NY
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-12208
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Albany, NY
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-13210
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Syracuse, NY
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-15213
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Pittsburgh, PA
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-17033
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Hershey, PA
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-19104
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Philadelphia, PA
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-19803
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Wilmington, DE
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-21215
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Baltimore, MD
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-23298
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Richmond, VA
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-23507
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Norfolk, VA
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-29203
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Columbia, SC
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-29605
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Greenville, SC
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-30322
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Atlanta, GA
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-32207
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Jacksonville, FL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-32504
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Pensacola, FL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-32610
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Gainesville, FL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-32806
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Orlando, FL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-33155
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Miami, FL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-33407
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: West Palm Beach, FL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-33607
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Tampa, FL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-33701
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: St. Petersburg, FL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-33901
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Fort Myers, FL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-35294
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Birmingham, AL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-37232
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Nashville, TN
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-39216
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Jackson, MS
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-40536
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Lexington, KY
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-43205
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Columbus, OH
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-44106
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Cleveland, OH
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-44195
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Cleveland, OH
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-44308
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Akron, OH
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-45229
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Cincinnati, OH
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-46202
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Indianapolis, IN
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-48109
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Ann Arbor, MI
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-48236
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Grosse Pointe Woods, MI
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-49503
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Grand Rapids, MI
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-53226
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Milwaukee, WI
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-55404
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Minneapolis, MN
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-55455
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Minneapolis, MN
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-55905
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Rochester, MN
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-60612
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Chicago, IL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-60614
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Chicago, IL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-62794
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Springfield, IL
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-63110
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: St. Louis, MO
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - NCT00831844-64108
Conditions: Adrenocortical Carcinoma - Kidney Cancer - Liver Cancer - Neuroblastoma - Retinoblastoma - Sarcoma
Location: Kansas City, MO
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|